title: Evaluation of class II major histocompatibility complex antigen expression for the differential diagnosis of cyclosporine A nephrotoxicity from kidney graft rejection.
authors.affiliation: Department of Nuclear Medicine, King's College Hospital, London, England.
authors.forename: M
authors.initials: M
authors.lastname: Barrett
authors.forename: A D
authors.initials: AD
authors.lastname: Milton
authors.forename: J
authors.initials: J
authors.lastname: Barrett
authors.forename: D
authors.initials: D
authors.lastname: Taube
authors.forename: M
authors.initials: M
authors.lastname: Bewick
authors.forename: V P
authors.initials: VP
authors.lastname: Parsons
authors.forename: J W
authors.initials: JW
authors.lastname: Fabre
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001707:Biopsy, Needle; D003524:Cyclosporins / Q000009:adverse effects* / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005802:Genes, MHC Class II; D006084:Graft Rejection / Q000187:drug effects / Q000276:immunology*; D000949:Histocompatibility Antigens Class II / Q000032:analysis*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use
chemical_list: D000961:Antilymphocyte Serum; D003524:Cyclosporins; D000949:Histocompatibility Antigens Class II; D011239:Prednisolone